Cephalon Inc. v. InnoPharma Inc. > Documents

Date Field	Doc. No.	Description (Pages)
Jan 25, 2019	6	ORDER granting motion to dismiss appeal pursuant to FRAP 42(b) [580683-2] filed by Appellants Hospira, Inc., InnoPharma Inc. and Cross-Appellant Cephalon Inc.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [580952] [17-2377, 17-2378] [JAB] [Entered: 01/25/2019 12:20 PM] (2)
May 15, 2018	4	MOTION of Cross-Appellant Cephalon Inc. to extend the time to 06/25/2018 to file the Cross-Appellant's Reply Brief. [Consent: unopposed]. Service: 05/15/2018 by email. [521660] [17-2378] [William Jay] [Entered: 05/15/2018 10:35 AM] (9)
May 15, 2018	5	NOTICE OF DEFICIENCY: The motion [4] filed by Cross-Appellant Cephalon Inc. was submitted in a trailer case and therefore cannot be accepted for filing. All filings must be submitted in lead appeal 17-2377 only. Service: 05/15/2018 by clerk. [521801] [MJL] [Entered: 05/15/2018 02:35 PM] (0)
Feb 28, 2018	3	ORDER filed. The motion [500849-2] is granted. The revised official caption is reflected in this order. Service: 02/28/2018 by clerk. [501854] [17-2377, 17-2378] [LMS] [Entered: 02/28/2018 03:56 PM] (2)
Aug 2, 2017	1	Appeal docketed. Received: 07/31/2017. [451022] [MJL] [Entered: 08/02/2017 04:08 PM] (119)
Aug 2, 2017	2	Note to file: The following cases are consolidated: 17-2377 (Lead) with 17-2378 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [451023] [17-2377, 17-2378] [MJL] [Entered: 08/02/2017 04:10 PM] (0)